1,721,495 research outputs found
sj-tif-1-taj-10.1177_20406223211041927 – Supplemental material for Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis
No full textSupplemental material, sj-tif-1-taj-10.1177_20406223211041927 for Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis by Seungwon Yang, Siyoung Yang, Young Kwon Jo, Seungyeon Kim, Min Jung Chang, Junjeong Choi, Jae Hee Cheon and Yun Mi Yu in Therapeutic Advances in Chronic Disease</p
sj-docx-1-taj-10.1177_20406223211041927 – Supplemental material for Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis
No full textSupplemental material, sj-docx-1-taj-10.1177_20406223211041927 for Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis by Seungwon Yang, Siyoung Yang, Young Kwon Jo, Seungyeon Kim, Min Jung Chang, Junjeong Choi, Jae Hee Cheon and Yun Mi Yu in Therapeutic Advances in Chronic Disease</p
sj-docx-3-taj-10.1177_20406223211041927 – Supplemental material for Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis
No full textSupplemental material, sj-docx-3-taj-10.1177_20406223211041927 for Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis by Seungwon Yang, Siyoung Yang, Young Kwon Jo, Seungyeon Kim, Min Jung Chang, Junjeong Choi, Jae Hee Cheon and Yun Mi Yu in Therapeutic Advances in Chronic Disease</p
sj-docx-2-taj-10.1177_20406223211041927 – Supplemental material for Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis
No full textSupplemental material, sj-docx-2-taj-10.1177_20406223211041927 for Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis by Seungwon Yang, Siyoung Yang, Young Kwon Jo, Seungyeon Kim, Min Jung Chang, Junjeong Choi, Jae Hee Cheon and Yun Mi Yu in Therapeutic Advances in Chronic Disease</p
sj-docx-4-tag-10.1177_17562848241227029 – Supplemental material for New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases
No full textSupplemental material, sj-docx-4-tag-10.1177_17562848241227029 for New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases by Jihye Park, I. Seul Park, Ji Hyung Kim, Jung Hyun Ji, Soo Jung Park, Jae Jun Park, Tae Il Kim, Seung Won Kim and Jae Hee Cheon in Therapeutic Advances in Gastroenterology</p
sj-doc-1-tag-10.1177_17562848241227029 – Supplemental material for New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases
No full textSupplemental material, sj-doc-1-tag-10.1177_17562848241227029 for New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases by Jihye Park, I. Seul Park, Ji Hyung Kim, Jung Hyun Ji, Soo Jung Park, Jae Jun Park, Tae Il Kim, Seung Won Kim and Jae Hee Cheon in Therapeutic Advances in Gastroenterology</p
sj-jpg-2-tag-10.1177_17562848241227029 – Supplemental material for New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases
No full textSupplemental material, sj-jpg-2-tag-10.1177_17562848241227029 for New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases by Jihye Park, I. Seul Park, Ji Hyung Kim, Jung Hyun Ji, Soo Jung Park, Jae Jun Park, Tae Il Kim, Seung Won Kim and Jae Hee Cheon in Therapeutic Advances in Gastroenterology</p
sj-jpg-3-tag-10.1177_17562848241227029 – Supplemental material for New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases
No full textSupplemental material, sj-jpg-3-tag-10.1177_17562848241227029 for New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases by Jihye Park, I. Seul Park, Ji Hyung Kim, Jung Hyun Ji, Soo Jung Park, Jae Jun Park, Tae Il Kim, Seung Won Kim and Jae Hee Cheon in Therapeutic Advances in Gastroenterology</p
Going Beyond Counting First Authors in Author Co-citation Analysis
Get PDFThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
- …
